We are a pharmaceutical technology startup and we want to position ourselves among the world's leading companies in the pharmaceutical market.
Proteoral® is today our main product and is the only universal device for the oral delivery of active therapeutic proteins in the bloodstream. Proteoral® brings evolution to the oral therapeutic protein market.

Technology


Our patented technology Proteoral®



Proteoral® is an excellent quality and innocuous product for use in oral polypeptide therapies. Proteoral®’s presence in the market benefits millions of lives worldwide.

PROTEORAL® COMBINED WITH DIFFERENT MOLECULES


Our preclinical studies on follicle stimulating hormone combined with Proteoral have consistently confirmed that 75% of the oral dose of FSH is absorbed in the bloodstream and successfully performs its therapeutic activity.

BENEFITS OF PROTEORAL ON THE MARKET

Therapeutic protein and Proteoral® in gastroprotected pills go past the stomach and it is released in the small intestine. There, Proteoral® opens the intercellular junctions of the small intestine epithelium and transports the active therapeutic proteins safely in the bloodstream.
The therapeutic proteins arrive at their site of action and successfully perform their therapeutic activity.

Applications

PROTEORAL® BENEFITS MILLIONS OF PEOPLE


Therapeutics areas of application of Proteoral® are fertility, insulin-dependent diabetes, rheumatoid arthritis, osteoporosis, cancer, autoimmune diseases and other conditions that use therapeutic proteins.

PROTEORAL® AND ITS THERAPEUTIC AREAS


 

STRATEGIC ALLIANCE AGREEMENTS



Thanks to Proteoral, our successfully signed and executed strategic alliance agreements with world leaders in the biopharmaceutical and technology industry generate new oral protein products commercialized in the global market.
Our product Proteoral is manufactured and marketed worldwide on a large scale with the highest excellence and quality standards. With Proteoral, we are totally successful in our value chain.